Park Medi World Limited has announced the incorporation of a new step-down subsidiary focused on healthcare and ancillary services, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made on May 04, 2026, and signed by Abhishek Kapoor, Company Secretary & Compliance Officer.

Proposed Subsidiary Details

The new entity is proposed to be named Healplus Medical Services Private Limited or Healplus Healthcare Private Limited, subject to approval by the Ministry of Corporate Affairs. The incorporation is yet to be completed, and the country of incorporation will be India. The proposed entity will operate in the healthcare services sector, dealing in healthcare and ancillary business lines.

The following table summarises the key details of the proposed incorporation as disclosed under the applicable SEBI regulations:

Corporate Structure and Shareholding

The proposed entity will be a wholly-owned subsidiary of Park Medicenters & Institutions Private Limited, which is an existing subsidiary of Park Medi World Limited. Consequently, the new entity will function as a step-down subsidiary of the listed company. Park Medi World Limited currently holds 81.81% equity shareholding in Park Medicenters & Institutions Private Limited.

The subscription to the shares of the proposed entity will be made through a cash consideration of INR 0.01 crore, to be paid by Park Medicenters & Institutions Private Limited along with its nominee.

Regulatory Compliance

The disclosure has been made in accordance with Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. No governmental or regulatory approvals are required for the incorporation of the proposed entity. The disclosure has also been disseminated on the company's official website at www.parkhospital.in .

Park medi world has attracted institutional investment from Vikas Khemani's Carnelian Bharat Amritkaal Fund, which has acquired a 1.04% stake in the company during the fourth quarter. This development highlights the growing institutional interest in the healthcare sector and Park Medi World's business operations.

Investment Details

The stake acquisition represents a notable addition to Park Medi World's institutional investor base. Carnelian Bharat Amritkaal Fund, managed by seasoned investor Vikas Khemani, has strategically positioned itself in the company with this investment.

Significance for Park Medi World

The investment from Carnelian Bharat Amritkaal Fund adds credibility to Park Medi World's growth story and business fundamentals. Vikas Khemani's reputation as an experienced investor in the Indian market makes this stake acquisition particularly noteworthy for existing and potential shareholders.

This institutional investment could potentially enhance the company's visibility among other institutional investors and contribute to improved market perception of Park Medi World's prospects in the healthcare sector.